TARS vs ZION · rev $336.0M vs P/E 11, rev $354.0M
Tarsus Pharmaceuticals Inc (TARS) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
TARS currently screens at market cap $2.66B. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the TARS and ZION stock pages for the full models.
Not investment advice.